Polyethylene Glycol 3350 Nf
Product Images NDC 58607-700

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Polyethylene Glycol 3350 Nf (NDC 58607-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Martin Ekwealor Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Me Polyglycol Label (Mepharma Polyglycol)

Label for Polyethylene Glycol 3350 NF PEGyLAX prescription powder for oral solution by M.E. Pharmaceuticals, Inc., NDC 58607-700-57. The label states the powder weight as 527 grams and includes dosing directions indicating a daily 17 gram dose, instructions for preparation with liquids, and storage conditions.*

FDA Label Image

Me Polyglycol1 Label (Mepharma Polyglycol1)

Patient information leaflet for Polyethylene Glycol 3350 NF PEGyLAX powder for oral solution. It includes instructions on dosage, administration, duration of use, and precautions. The leaflet covers side effects, product description, clinical pharmacology, and clinical trials related to Polyethylene Glycol 3350 NF.*

FDA Label Image

Me Polyglycol2 Label (Mepharma Polyglycol2)

This text panel provides information on Polyethylene Glycol 3350 NF PEGyLAX, including study findings on bowel movement frequency, indications for use in occasional constipation, contraindications for patients with bowel obstruction or allergy to polyethylene glycol, warnings about symptoms to rule out before treatment, and precautions emphasizing medical history, physical exams, and lifestyle advice.*

FDA Label Image

Me Polyglycol3 Label (Mepharma Polyglycol3)

This image shows a text panel titled 'Information for Patients' for Polyethylene Glycol 3350 NF. It provides details on the product's effect on stool softening, instructions for use, potential effects on laboratory tests, drug interactions, carcinogenicity and reproductive toxicity studies, pregnancy category, pediatric and geriatric use guidance, and adverse reactions guidance.*

FDA Label Image

Me Polyglycol4 Label (Mepharma Polyglycol4)

This drug facts panel for Polyethylene Glycol 3350 NF PEGyLAX includes information on possible side effects such as nausea, abdominal bloating, cramping, and flatulence. It covers overdose details, dosage and administration instructions specifying a 17-gram dose dissolved in liquids, storage conditions between 20°-25°C (68°-77°F), and manufacturer information for M.E. Pharmaceuticals, Inc. in Richmond, IN. The label also features a U.S. flag with the text 'Made with Pride in the U.S.A.'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.